Abstract:POSTERSCD40 ligand (CD40L) and its receptor CD40 on DC is essential for DCactivation and for induction of antigen-specific T-cells responses.In this study, DC pulsed with tumor-lysate and subsequently transduced with an adenovirus (Ad) encoding murine CD40L were injected intratumorally, subcutaneously or intravenously to treat pre-established HCC-tumors in vivo.Methods: Two Ad were generated: Ad-CD40L and Ad-LacZ (encoding LacZ).DC were obtained from bone marrow of C3H-HeNcrl mice and cultured with GM-CSF and 1L-4.DC were pulsed with tumor lysate on day 5 and transduced with adenoviruses (MOI 250) on day 6.Expression of CD40L, CD80 and CD86 was assayed by flow cytometry and TL-12-expression by ELTSA.Subcutaneous HCC-tumors were induced by inoculation of 106 Hepal 29-cells into the right flank ofmice.When tumor volume was 100-200mm3, injection of DC was performed.Results: Transduction of DC with Ad-CD40L induced a strong 1L-12expression of >200 ng/ml/l06 DC in their supernatant.The intratumoral (i.t.)-injection of CD40L-expressing DC induced a significant tumor inhibition of >60% compared to mice treated with LacZ-transduced DC (p i 0.002).Moreover, tumor growth inhibition was significantly higher after it.-DC-applicationthan after S.C. or i.v.treatment: 17 days after tumor induction, the mean tumor volume was 477.5+120 mm3 in i.t.-treated animals vs. 1050.4f167.2 mm3 in i.v.-treated animals, p = 0.02 I . 2 1 days after tumor induction, the mean of tumor volume was 663.1Zt140.7mm' in i.t.treated animals vs. 1374.3&165.4mm3 in s.c.-treated animals (p= 0.0273).The s.c.-application of DC showed also an inhibition oftumor growth compared to the s.c.-treatment with LacZ-expressing DC (p i 0.05) and was significantly more effective than i.v.-administration of CD40L-transduced DC (531.6Zt111.3mm3 vs. 1050.4&167.2mm3on day 21 respectively, p = 0.0323).Conclusions: Our data show that transduction of tumor lysate pulsed DC with Ad-CD40L yields a high CD40L-and IL-12-expression in DC, which could induce a tumor regression of pre-established S.C. hepatocellular tumors.1.t.-application of these engineered DC was more effective than the s.c. or i.v.-injection of these DC.These results favor it.-injection of CD40L-expressing DC for immunotherapy of hepatocellular tumors.

DCN Prevent Metastasis of HepG2 Cells by Elevating the Expression of TGF Β and P15

HBx downregulated decorin and decorin-derived peptides inhibit the proliferation and tumorigenicity of hepatocellular carcinoma cells

Effect of Decorin Gene Overexpression on Migration and Invasion of Cholangiocarcinoma Cells

Effect of Dendritic Cell-Based Immunotherapy on Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Influences of recombinant decorin gene transfection on p21WAF1/CIP1 of HepG2 hepatoma cells

DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth

DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth.

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma

Methylated+58cpg Site Decreases Dcn Mrna Expression And Enhances Tgf-Beta/Smad Signaling In Nsclc Cells With High Metastatic Potential

TXNDC12 Promotes EMT and Metastasis of Hepatocellular Carcinoma Cells Via Activation of Β-Catenin

CNDP1 Suppresses the Malignant Behavior of Hepatoma Cell via Restricting PI3K-AKT-mTOR Activation

Cytokine-induced Killer Cells Combined with Dendritic Cells Inhibited Liver Cancer Cells.

[Effects and mechanism of decorin on the proliferation of HuH7 hepatoma carcinoma cells in vitro]

NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling

Co-culture of Dendritic Cells and Cytokine-Induced Killer Cells Effectively Suppresses Liver Cancer Stem Cell Growth by Inhibiting Pathways in the Immune System

Study on Anti-mouse Hepatocellular Carcinoma Effect of Cytokine-induced Kill Cells Activated by Dendritic Cells Transfected with Mouse Hepatocellular Carcinoma Total RNA in Vitro

Pan‐cancer analysis of DCTN2 and its tumour‐promoting role in HCC by modulating the AKT pathway

Recombinant human decorin upregulates P57KIP2 expression in HepG2 hepatoma cell lines

The Iron Chelator Dp44mt Inhibits Hepatocellular Carcinoma Metastasis Via N-Myc Downstream-Regulated Gene 2 (Ndrg2)/Gp130/Stat3 Pathway

Immunotherapy of Patient with Hepatocellular Carcinoma Using Cytotoxic T Lymphocytes Ex Vivo Activated with Tumor Antigen-Pulsed Dendritic Cells

[388] PEG10 IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND IS A POTENTIAL TARGET FOR HEPATOCELLULAR CARCINOMA GENE THERAPHY